A guideline for the diagnosis and management of ... - MPN Voice

MPN Voice

10,722 members14,842 posts

A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline

PVPVPV profile image
0 Replies

My haematologist, Dr Francis at Sheffield Hallamshire Hospital, was thoughtful enough to point this out to me and gave me the reference. He told me that, based on the guidelines, he wanted to increase my hydroxy rather than send me for my usual venesection. I understand this is because I am now over 65 and therefore classed as a higher risk. I think next time round I might tell him I prefer a mix as I would prefer not to keep increasing my hydroxy dose. However, we are not doctors and should follow advice if we trust the doctor.

See onlinelibrary.wiley.com/doi...

"Randomised trial data supports that venesection of 200–500 ml blood at intervals suitable for patient size/tolerability should be used to achieve and maintain a Hct of <0·45 (Marchioli et al, 2013). In low risk patients this is usually adequate to maintain target Hct. Where frequent venesection is needed to achieve this target then an alternative approach using a cytoreductive agent may need to be considered. High levels of venesection requirement have been reported to have an association with higher thrombosis risk in patients on HC, specifically in those patients requiring 3 or more venesections per year (Alvarez‐Larrán et al, 2017). "

Written by
PVPVPV profile image
PVPVPV
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management

 https://onlinelibrary.wiley.com/doi/full/10.1002/ajh.27002 « Survival and Prognosis Median...

Outcomes of JAK2 V617F-positive polycythemia vera and ET according to the JAK2 V617F allele burden

« JAK2 V617F allele burdens were positively correlated with white blood cell counts, hemoglobin...

A recent diagnosis of polycythaemia.

I am new here. I was given a diagnosis of polycythaemia in January this year, and was told I had...

NICE Final Guidance on Ruxolitinib for the treatment of Polycythaemia Vera

We are delighted to announce that NICE (the National Institute for Health and Care Excellence) has...

Slightly disconcerting review

Four hours later than scheduled, my haem called to say that she thought I’d benefit from a...